Date and time: Tuesday November 3, 2020, 14:00 – 17:00 (Central European Time, CET)
Organization: Clinical lipidomics interest group in International Lipidomics Society, free to everyone, online using Zoom
Please note that the meeting has a new link below which requires registration via Zoom!
|14:00 – 14:10||Michal Holčapek (University of Pardubice, Czech Republic) – Welcome and opening|
|14:10 – 14:40||Timothy J. Garrett (University of Florida, Gainesville, FL, USA) – Lost in translation, a research mass spectrometrist in clinical pathology|
|14:40 – 15:10||Michael Vogeser (University of Munich (LMU), Germany) – Lipidomics-based in-vitro diagnostics – a clinical pathologist‘s perspective|
|15:10 – 15:25||Günter Fauler (Medical University of Graz, Austria) – Routine analysis of lipids, a lot of challenges in a clinical laboratory|
|15:25 – 15:40||Hans-F. Schött (SLING – Singapore Lipidomics Incubator, Singapore) – Steroids as diagnostic markers for inherited lipid metabolic disorders|
|15:40 – 15:55||Uliana Danilenko (Centers for Disease Control and Prevention, Atlanta, GA, USA) – CDC Clinical Standardization Programs to improve accuracy and reliability of biomarker measurements in patient care and research|
|15:55 – 16:10||Russell P. Grant (LabCorp, Burlington, NC, USA) – Analysis of Lipophilic Vitamins and The Slippery Slope of Perfection|
|16:10 – 16:40||Elisabeth Erhardtsen (Nordic Bioscience, Denmark) – Regulatory pathways for approval of biomarkers|
|16:40 – 17:00||Discussion|
Topics: regulatory requirements to achieve approval to market for new biomarker(s), clinical validation, single biomarker vs. analyte panel (large or small) and how to quantitate according to regulatory requirements, certified reference materials, calibrators, lipid class or lipid species internal standards.
Michal Holčapek, Anne K. Bendt, Michael Vogeser, and Peter Meikle
Steering committee of Clinical lipidomics IG